PHILADELPHIA (MedPage Today) -- Combined results from two extension trials of the investigational drug drisapersen for Duchenne muscular dystrophy (DMD) showed a suggestion of benefit, but only for a subset of patients. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment